Global Artificial Tendons and Ligaments

Artificial Tendons and Ligaments Comprehensive Study by Application (Knee Injuries, Shoulder Injuries, Foot and Ankle Injuries, Others), Implant Type (Silastic-Rod Implant, Carbon-Fiber Implant, Marlex Mesh), Material Type (Carbon, Carbon & Polyester, Leeds-Keio Polyester, Dacron, Bovine Glutaraldehyde-Fixed Xenograft, Gore-Tex Polytetrafluoroethylene), End-Use (Hospitals, Clinics, Ambulatory Surgery Centers) Players and Region - Global Market Outlook to 2028

Artificial Tendons and Ligaments Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Artificial Tendons and Ligaments Market?

Ligaments and tendons are connective tissues formed by the dense ligaments of collagenous fibers. The ligament connects bone to bone, while the tendons connect the bone to the muscle to stabilize movement when forces are applied to it. The artificial tendons and ligaments are intended to reinforce or replace the existing ligament. The artificial ligament and tendon are replaced by the artificial ligament and tendon due to injuries and related illnesses, sports injuries, less diet or misalignments, and other diseases. The ribbon is of two types as white and yellow ribbon. The white band is rich in collagen fibers while the yellow band is rich in elastic fibers. An artificial tendon is a reinforcement fabric that is used to replace a torn tendon. The artificial tendon consists of bio-component fibers such as polyacrylonitrile fibers, polypropylene, PET, or PolyNaSS poly. They are used to repair Achilles tendons. An artificial ligament acts as a backing and temporary replacement while a new tendon sheath develops. These are used to replace a torn ligament such as the anterior cruciate ligament. With the rise in Covid-19 infections worldwide, there are also growing concerns about the lack of life-saving devices and other important medical aids to prevent the spread of this pandemic and to provide optimal care for those infected.

Highlights from Artificial Tendons and Ligaments Market Study
AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)
Key Companies ProfiledLars (France), Corin Group (United Kingdom), Neoligaments (Xiros) (United Kingdom), Cousin Biotech (France), FX Solutions (France), Orthomed S.A.S. (France), Shanghai Pine&Power Biotech (China) and Mathys AG Bettlach (Switzerland)


The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products, and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that European Players will contribute to the maximum growth of Global Artificial Tendons and Ligaments market throughout the forecasted period.

Lars (France), Corin Group (United Kingdom), Neoligaments (Xiros) (United Kingdom), Cousin Biotech (France), FX Solutions (France), Orthomed S.A.S. (France), Shanghai Pine&Power Biotech (China) and Mathys AG Bettlach (Switzerland) are some of the key players profiled in the study.

Artificial Tendons and Ligaments Market Segmentation:
ScopeSub-Segments
Application / End UserKnee Injuries, Shoulder Injuries, Foot and Ankle Injuries and Others
Implant TypeSilastic-Rod Implant,Carbon-Fiber Implant,Marlex Mesh
Material TypeCarbon,Carbon & Polyester,Leeds-Keio Polyester,Dacron,Bovine Glutaraldehyde-Fixed Xenograft,Gore-Tex Polytetrafluoroethylene
End-UseHospitals,Clinics,Ambulatory Surgery Centers


On the basis of geography, the market of Artificial Tendons and Ligaments has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
The Growing Medical Devices Industry, Increasing Preference for Minimally Invasive Surgeries and Minimal Out-Of-Pocket Expenditure for Medical Devices

Market Growth Drivers:
Increasing Sports-Related Injuries, Favorable Reimbursement Policies, Increasing Aging Population and Rising Cases of Knee Replacements

Challenges:
The Various Risks, Notably That of Inflammation of the Synovial Membrane in Patients and Inadequate Reimbursement Policies

Restraints:
The High Cost of the Treatment and The Lack of Willingness to Use Artificial Tendons and Ligaments among Healthcare Services

Opportunities:
The Increasing Number of Government Initiatives to Encourage Sports, Advancements in Surgical Procedures and Growing Initiatives to Increase the Awareness about Artificial Tendons and Ligaments

Key Target Audience
Providers of Artificial Tendons and Ligaments, Potential Investors, Market Research Firms, Regulatory Bodies, End-Users and Others

Market Leaders & Development Strategies
In June 2018 Corin established its new headquarters and manufacturing facility in the UK. This strategic initiative should increase the company's production and sales capacity and further support growth in the local and global markets.



Report Objectives / Segmentation Covered

By Application
  • Knee Injuries
  • Shoulder Injuries
  • Foot and Ankle Injuries
  • Others
By Implant Type
  • Silastic-Rod Implant
  • Carbon-Fiber Implant
  • Marlex Mesh

By Material Type
  • Carbon
  • Carbon & Polyester
  • Leeds-Keio Polyester
  • Dacron
  • Bovine Glutaraldehyde-Fixed Xenograft
  • Gore-Tex Polytetrafluoroethylene

By End-Use
  • Hospitals
  • Clinics
  • Ambulatory Surgery Centers

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Sports-Related Injuries
      • 3.2.2. Favorable Reimbursement Policies
      • 3.2.3. Increasing Aging Population
      • 3.2.4. Rising Cases of Knee Replacements
    • 3.3. Market Challenges
      • 3.3.1. The Various Risks, Notably That of Inflammation of the Synovial Membrane in Patients
      • 3.3.2. Inadequate Reimbursement Policies
    • 3.4. Market Trends
      • 3.4.1. The Growing Medical Devices Industry
      • 3.4.2. Increasing Preference for Minimally Invasive Surgeries
      • 3.4.3. Minimal Out-Of-Pocket Expenditure for Medical Devices
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Artificial Tendons and Ligaments, by Application, Implant Type, Material Type, End-Use and Region (value and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Artificial Tendons and Ligaments (Value)
      • 5.2.1. Global Artificial Tendons and Ligaments by: Application (Value)
        • 5.2.1.1. Knee Injuries
        • 5.2.1.2. Shoulder Injuries
        • 5.2.1.3. Foot and Ankle Injuries
        • 5.2.1.4. Others
      • 5.2.2. Global Artificial Tendons and Ligaments by: Implant Type (Value)
        • 5.2.2.1. Silastic-Rod Implant
        • 5.2.2.2. Carbon-Fiber Implant
        • 5.2.2.3. Marlex Mesh
      • 5.2.3. Global Artificial Tendons and Ligaments by: Material Type (Value)
        • 5.2.3.1. Carbon
        • 5.2.3.2. Carbon & Polyester
        • 5.2.3.3. Leeds-Keio Polyester
        • 5.2.3.4. Dacron
        • 5.2.3.5. Bovine Glutaraldehyde-Fixed Xenograft
        • 5.2.3.6. Gore-Tex Polytetrafluoroethylene
      • 5.2.4. Global Artificial Tendons and Ligaments by: End-Use (Value)
        • 5.2.4.1. Hospitals
        • 5.2.4.2. Clinics
        • 5.2.4.3. Ambulatory Surgery Centers
      • 5.2.5. Global Artificial Tendons and Ligaments Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Artificial Tendons and Ligaments (Price)
  • 6. Artificial Tendons and Ligaments: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Lars (France)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Corin Group (United Kingdom)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Neoligaments (Xiros) (United Kingdom)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Cousin Biotech (France)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. FX Solutions (France)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Orthomed S.A.S. (France)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Shanghai Pine&Power Biotech (China)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Mathys AG Bettlach (Switzerland)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
  • 7. Global Artificial Tendons and Ligaments Sale, by Application, Implant Type, Material Type, End-Use and Region (value and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Artificial Tendons and Ligaments (Value)
      • 7.2.1. Global Artificial Tendons and Ligaments by: Application (Value)
        • 7.2.1.1. Knee Injuries
        • 7.2.1.2. Shoulder Injuries
        • 7.2.1.3. Foot and Ankle Injuries
        • 7.2.1.4. Others
      • 7.2.2. Global Artificial Tendons and Ligaments by: Implant Type (Value)
        • 7.2.2.1. Silastic-Rod Implant
        • 7.2.2.2. Carbon-Fiber Implant
        • 7.2.2.3. Marlex Mesh
      • 7.2.3. Global Artificial Tendons and Ligaments by: Material Type (Value)
        • 7.2.3.1. Carbon
        • 7.2.3.2. Carbon & Polyester
        • 7.2.3.3. Leeds-Keio Polyester
        • 7.2.3.4. Dacron
        • 7.2.3.5. Bovine Glutaraldehyde-Fixed Xenograft
        • 7.2.3.6. Gore-Tex Polytetrafluoroethylene
      • 7.2.4. Global Artificial Tendons and Ligaments by: End-Use (Value)
        • 7.2.4.1. Hospitals
        • 7.2.4.2. Clinics
        • 7.2.4.3. Ambulatory Surgery Centers
      • 7.2.5. Global Artificial Tendons and Ligaments Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Artificial Tendons and Ligaments (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Artificial Tendons and Ligaments: by Application(USD Million)
  • Table 2. Artificial Tendons and Ligaments Knee Injuries , by Region USD Million (2017-2022)
  • Table 3. Artificial Tendons and Ligaments Shoulder Injuries , by Region USD Million (2017-2022)
  • Table 4. Artificial Tendons and Ligaments Foot and Ankle Injuries , by Region USD Million (2017-2022)
  • Table 5. Artificial Tendons and Ligaments Others , by Region USD Million (2017-2022)
  • Table 6. Artificial Tendons and Ligaments: by Implant Type(USD Million)
  • Table 7. Artificial Tendons and Ligaments Silastic-Rod Implant , by Region USD Million (2017-2022)
  • Table 8. Artificial Tendons and Ligaments Carbon-Fiber Implant , by Region USD Million (2017-2022)
  • Table 9. Artificial Tendons and Ligaments Marlex Mesh , by Region USD Million (2017-2022)
  • Table 10. Artificial Tendons and Ligaments: by Material Type(USD Million)
  • Table 11. Artificial Tendons and Ligaments Carbon , by Region USD Million (2017-2022)
  • Table 12. Artificial Tendons and Ligaments Carbon & Polyester , by Region USD Million (2017-2022)
  • Table 13. Artificial Tendons and Ligaments Leeds-Keio Polyester , by Region USD Million (2017-2022)
  • Table 14. Artificial Tendons and Ligaments Dacron , by Region USD Million (2017-2022)
  • Table 15. Artificial Tendons and Ligaments Bovine Glutaraldehyde-Fixed Xenograft , by Region USD Million (2017-2022)
  • Table 16. Artificial Tendons and Ligaments Gore-Tex Polytetrafluoroethylene , by Region USD Million (2017-2022)
  • Table 17. Artificial Tendons and Ligaments: by End-Use(USD Million)
  • Table 18. Artificial Tendons and Ligaments Hospitals , by Region USD Million (2017-2022)
  • Table 19. Artificial Tendons and Ligaments Clinics , by Region USD Million (2017-2022)
  • Table 20. Artificial Tendons and Ligaments Ambulatory Surgery Centers , by Region USD Million (2017-2022)
  • Table 21. South America Artificial Tendons and Ligaments, by Country USD Million (2017-2022)
  • Table 22. South America Artificial Tendons and Ligaments, by Application USD Million (2017-2022)
  • Table 23. South America Artificial Tendons and Ligaments, by Implant Type USD Million (2017-2022)
  • Table 24. South America Artificial Tendons and Ligaments, by Material Type USD Million (2017-2022)
  • Table 25. South America Artificial Tendons and Ligaments, by End-Use USD Million (2017-2022)
  • Table 26. Brazil Artificial Tendons and Ligaments, by Application USD Million (2017-2022)
  • Table 27. Brazil Artificial Tendons and Ligaments, by Implant Type USD Million (2017-2022)
  • Table 28. Brazil Artificial Tendons and Ligaments, by Material Type USD Million (2017-2022)
  • Table 29. Brazil Artificial Tendons and Ligaments, by End-Use USD Million (2017-2022)
  • Table 30. Argentina Artificial Tendons and Ligaments, by Application USD Million (2017-2022)
  • Table 31. Argentina Artificial Tendons and Ligaments, by Implant Type USD Million (2017-2022)
  • Table 32. Argentina Artificial Tendons and Ligaments, by Material Type USD Million (2017-2022)
  • Table 33. Argentina Artificial Tendons and Ligaments, by End-Use USD Million (2017-2022)
  • Table 34. Rest of South America Artificial Tendons and Ligaments, by Application USD Million (2017-2022)
  • Table 35. Rest of South America Artificial Tendons and Ligaments, by Implant Type USD Million (2017-2022)
  • Table 36. Rest of South America Artificial Tendons and Ligaments, by Material Type USD Million (2017-2022)
  • Table 37. Rest of South America Artificial Tendons and Ligaments, by End-Use USD Million (2017-2022)
  • Table 38. Asia Pacific Artificial Tendons and Ligaments, by Country USD Million (2017-2022)
  • Table 39. Asia Pacific Artificial Tendons and Ligaments, by Application USD Million (2017-2022)
  • Table 40. Asia Pacific Artificial Tendons and Ligaments, by Implant Type USD Million (2017-2022)
  • Table 41. Asia Pacific Artificial Tendons and Ligaments, by Material Type USD Million (2017-2022)
  • Table 42. Asia Pacific Artificial Tendons and Ligaments, by End-Use USD Million (2017-2022)
  • Table 43. China Artificial Tendons and Ligaments, by Application USD Million (2017-2022)
  • Table 44. China Artificial Tendons and Ligaments, by Implant Type USD Million (2017-2022)
  • Table 45. China Artificial Tendons and Ligaments, by Material Type USD Million (2017-2022)
  • Table 46. China Artificial Tendons and Ligaments, by End-Use USD Million (2017-2022)
  • Table 47. Japan Artificial Tendons and Ligaments, by Application USD Million (2017-2022)
  • Table 48. Japan Artificial Tendons and Ligaments, by Implant Type USD Million (2017-2022)
  • Table 49. Japan Artificial Tendons and Ligaments, by Material Type USD Million (2017-2022)
  • Table 50. Japan Artificial Tendons and Ligaments, by End-Use USD Million (2017-2022)
  • Table 51. India Artificial Tendons and Ligaments, by Application USD Million (2017-2022)
  • Table 52. India Artificial Tendons and Ligaments, by Implant Type USD Million (2017-2022)
  • Table 53. India Artificial Tendons and Ligaments, by Material Type USD Million (2017-2022)
  • Table 54. India Artificial Tendons and Ligaments, by End-Use USD Million (2017-2022)
  • Table 55. South Korea Artificial Tendons and Ligaments, by Application USD Million (2017-2022)
  • Table 56. South Korea Artificial Tendons and Ligaments, by Implant Type USD Million (2017-2022)
  • Table 57. South Korea Artificial Tendons and Ligaments, by Material Type USD Million (2017-2022)
  • Table 58. South Korea Artificial Tendons and Ligaments, by End-Use USD Million (2017-2022)
  • Table 59. Taiwan Artificial Tendons and Ligaments, by Application USD Million (2017-2022)
  • Table 60. Taiwan Artificial Tendons and Ligaments, by Implant Type USD Million (2017-2022)
  • Table 61. Taiwan Artificial Tendons and Ligaments, by Material Type USD Million (2017-2022)
  • Table 62. Taiwan Artificial Tendons and Ligaments, by End-Use USD Million (2017-2022)
  • Table 63. Australia Artificial Tendons and Ligaments, by Application USD Million (2017-2022)
  • Table 64. Australia Artificial Tendons and Ligaments, by Implant Type USD Million (2017-2022)
  • Table 65. Australia Artificial Tendons and Ligaments, by Material Type USD Million (2017-2022)
  • Table 66. Australia Artificial Tendons and Ligaments, by End-Use USD Million (2017-2022)
  • Table 67. Rest of Asia-Pacific Artificial Tendons and Ligaments, by Application USD Million (2017-2022)
  • Table 68. Rest of Asia-Pacific Artificial Tendons and Ligaments, by Implant Type USD Million (2017-2022)
  • Table 69. Rest of Asia-Pacific Artificial Tendons and Ligaments, by Material Type USD Million (2017-2022)
  • Table 70. Rest of Asia-Pacific Artificial Tendons and Ligaments, by End-Use USD Million (2017-2022)
  • Table 71. Europe Artificial Tendons and Ligaments, by Country USD Million (2017-2022)
  • Table 72. Europe Artificial Tendons and Ligaments, by Application USD Million (2017-2022)
  • Table 73. Europe Artificial Tendons and Ligaments, by Implant Type USD Million (2017-2022)
  • Table 74. Europe Artificial Tendons and Ligaments, by Material Type USD Million (2017-2022)
  • Table 75. Europe Artificial Tendons and Ligaments, by End-Use USD Million (2017-2022)
  • Table 76. Germany Artificial Tendons and Ligaments, by Application USD Million (2017-2022)
  • Table 77. Germany Artificial Tendons and Ligaments, by Implant Type USD Million (2017-2022)
  • Table 78. Germany Artificial Tendons and Ligaments, by Material Type USD Million (2017-2022)
  • Table 79. Germany Artificial Tendons and Ligaments, by End-Use USD Million (2017-2022)
  • Table 80. France Artificial Tendons and Ligaments, by Application USD Million (2017-2022)
  • Table 81. France Artificial Tendons and Ligaments, by Implant Type USD Million (2017-2022)
  • Table 82. France Artificial Tendons and Ligaments, by Material Type USD Million (2017-2022)
  • Table 83. France Artificial Tendons and Ligaments, by End-Use USD Million (2017-2022)
  • Table 84. Italy Artificial Tendons and Ligaments, by Application USD Million (2017-2022)
  • Table 85. Italy Artificial Tendons and Ligaments, by Implant Type USD Million (2017-2022)
  • Table 86. Italy Artificial Tendons and Ligaments, by Material Type USD Million (2017-2022)
  • Table 87. Italy Artificial Tendons and Ligaments, by End-Use USD Million (2017-2022)
  • Table 88. United Kingdom Artificial Tendons and Ligaments, by Application USD Million (2017-2022)
  • Table 89. United Kingdom Artificial Tendons and Ligaments, by Implant Type USD Million (2017-2022)
  • Table 90. United Kingdom Artificial Tendons and Ligaments, by Material Type USD Million (2017-2022)
  • Table 91. United Kingdom Artificial Tendons and Ligaments, by End-Use USD Million (2017-2022)
  • Table 92. Netherlands Artificial Tendons and Ligaments, by Application USD Million (2017-2022)
  • Table 93. Netherlands Artificial Tendons and Ligaments, by Implant Type USD Million (2017-2022)
  • Table 94. Netherlands Artificial Tendons and Ligaments, by Material Type USD Million (2017-2022)
  • Table 95. Netherlands Artificial Tendons and Ligaments, by End-Use USD Million (2017-2022)
  • Table 96. Rest of Europe Artificial Tendons and Ligaments, by Application USD Million (2017-2022)
  • Table 97. Rest of Europe Artificial Tendons and Ligaments, by Implant Type USD Million (2017-2022)
  • Table 98. Rest of Europe Artificial Tendons and Ligaments, by Material Type USD Million (2017-2022)
  • Table 99. Rest of Europe Artificial Tendons and Ligaments, by End-Use USD Million (2017-2022)
  • Table 100. MEA Artificial Tendons and Ligaments, by Country USD Million (2017-2022)
  • Table 101. MEA Artificial Tendons and Ligaments, by Application USD Million (2017-2022)
  • Table 102. MEA Artificial Tendons and Ligaments, by Implant Type USD Million (2017-2022)
  • Table 103. MEA Artificial Tendons and Ligaments, by Material Type USD Million (2017-2022)
  • Table 104. MEA Artificial Tendons and Ligaments, by End-Use USD Million (2017-2022)
  • Table 105. Middle East Artificial Tendons and Ligaments, by Application USD Million (2017-2022)
  • Table 106. Middle East Artificial Tendons and Ligaments, by Implant Type USD Million (2017-2022)
  • Table 107. Middle East Artificial Tendons and Ligaments, by Material Type USD Million (2017-2022)
  • Table 108. Middle East Artificial Tendons and Ligaments, by End-Use USD Million (2017-2022)
  • Table 109. Africa Artificial Tendons and Ligaments, by Application USD Million (2017-2022)
  • Table 110. Africa Artificial Tendons and Ligaments, by Implant Type USD Million (2017-2022)
  • Table 111. Africa Artificial Tendons and Ligaments, by Material Type USD Million (2017-2022)
  • Table 112. Africa Artificial Tendons and Ligaments, by End-Use USD Million (2017-2022)
  • Table 113. North America Artificial Tendons and Ligaments, by Country USD Million (2017-2022)
  • Table 114. North America Artificial Tendons and Ligaments, by Application USD Million (2017-2022)
  • Table 115. North America Artificial Tendons and Ligaments, by Implant Type USD Million (2017-2022)
  • Table 116. North America Artificial Tendons and Ligaments, by Material Type USD Million (2017-2022)
  • Table 117. North America Artificial Tendons and Ligaments, by End-Use USD Million (2017-2022)
  • Table 118. United States Artificial Tendons and Ligaments, by Application USD Million (2017-2022)
  • Table 119. United States Artificial Tendons and Ligaments, by Implant Type USD Million (2017-2022)
  • Table 120. United States Artificial Tendons and Ligaments, by Material Type USD Million (2017-2022)
  • Table 121. United States Artificial Tendons and Ligaments, by End-Use USD Million (2017-2022)
  • Table 122. Canada Artificial Tendons and Ligaments, by Application USD Million (2017-2022)
  • Table 123. Canada Artificial Tendons and Ligaments, by Implant Type USD Million (2017-2022)
  • Table 124. Canada Artificial Tendons and Ligaments, by Material Type USD Million (2017-2022)
  • Table 125. Canada Artificial Tendons and Ligaments, by End-Use USD Million (2017-2022)
  • Table 126. Mexico Artificial Tendons and Ligaments, by Application USD Million (2017-2022)
  • Table 127. Mexico Artificial Tendons and Ligaments, by Implant Type USD Million (2017-2022)
  • Table 128. Mexico Artificial Tendons and Ligaments, by Material Type USD Million (2017-2022)
  • Table 129. Mexico Artificial Tendons and Ligaments, by End-Use USD Million (2017-2022)
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Artificial Tendons and Ligaments: by Application(USD Million)
  • Table 139. Artificial Tendons and Ligaments Knee Injuries , by Region USD Million (2023-2028)
  • Table 140. Artificial Tendons and Ligaments Shoulder Injuries , by Region USD Million (2023-2028)
  • Table 141. Artificial Tendons and Ligaments Foot and Ankle Injuries , by Region USD Million (2023-2028)
  • Table 142. Artificial Tendons and Ligaments Others , by Region USD Million (2023-2028)
  • Table 143. Artificial Tendons and Ligaments: by Implant Type(USD Million)
  • Table 144. Artificial Tendons and Ligaments Silastic-Rod Implant , by Region USD Million (2023-2028)
  • Table 145. Artificial Tendons and Ligaments Carbon-Fiber Implant , by Region USD Million (2023-2028)
  • Table 146. Artificial Tendons and Ligaments Marlex Mesh , by Region USD Million (2023-2028)
  • Table 147. Artificial Tendons and Ligaments: by Material Type(USD Million)
  • Table 148. Artificial Tendons and Ligaments Carbon , by Region USD Million (2023-2028)
  • Table 149. Artificial Tendons and Ligaments Carbon & Polyester , by Region USD Million (2023-2028)
  • Table 150. Artificial Tendons and Ligaments Leeds-Keio Polyester , by Region USD Million (2023-2028)
  • Table 151. Artificial Tendons and Ligaments Dacron , by Region USD Million (2023-2028)
  • Table 152. Artificial Tendons and Ligaments Bovine Glutaraldehyde-Fixed Xenograft , by Region USD Million (2023-2028)
  • Table 153. Artificial Tendons and Ligaments Gore-Tex Polytetrafluoroethylene , by Region USD Million (2023-2028)
  • Table 154. Artificial Tendons and Ligaments: by End-Use(USD Million)
  • Table 155. Artificial Tendons and Ligaments Hospitals , by Region USD Million (2023-2028)
  • Table 156. Artificial Tendons and Ligaments Clinics , by Region USD Million (2023-2028)
  • Table 157. Artificial Tendons and Ligaments Ambulatory Surgery Centers , by Region USD Million (2023-2028)
  • Table 158. South America Artificial Tendons and Ligaments, by Country USD Million (2023-2028)
  • Table 159. South America Artificial Tendons and Ligaments, by Application USD Million (2023-2028)
  • Table 160. South America Artificial Tendons and Ligaments, by Implant Type USD Million (2023-2028)
  • Table 161. South America Artificial Tendons and Ligaments, by Material Type USD Million (2023-2028)
  • Table 162. South America Artificial Tendons and Ligaments, by End-Use USD Million (2023-2028)
  • Table 163. Brazil Artificial Tendons and Ligaments, by Application USD Million (2023-2028)
  • Table 164. Brazil Artificial Tendons and Ligaments, by Implant Type USD Million (2023-2028)
  • Table 165. Brazil Artificial Tendons and Ligaments, by Material Type USD Million (2023-2028)
  • Table 166. Brazil Artificial Tendons and Ligaments, by End-Use USD Million (2023-2028)
  • Table 167. Argentina Artificial Tendons and Ligaments, by Application USD Million (2023-2028)
  • Table 168. Argentina Artificial Tendons and Ligaments, by Implant Type USD Million (2023-2028)
  • Table 169. Argentina Artificial Tendons and Ligaments, by Material Type USD Million (2023-2028)
  • Table 170. Argentina Artificial Tendons and Ligaments, by End-Use USD Million (2023-2028)
  • Table 171. Rest of South America Artificial Tendons and Ligaments, by Application USD Million (2023-2028)
  • Table 172. Rest of South America Artificial Tendons and Ligaments, by Implant Type USD Million (2023-2028)
  • Table 173. Rest of South America Artificial Tendons and Ligaments, by Material Type USD Million (2023-2028)
  • Table 174. Rest of South America Artificial Tendons and Ligaments, by End-Use USD Million (2023-2028)
  • Table 175. Asia Pacific Artificial Tendons and Ligaments, by Country USD Million (2023-2028)
  • Table 176. Asia Pacific Artificial Tendons and Ligaments, by Application USD Million (2023-2028)
  • Table 177. Asia Pacific Artificial Tendons and Ligaments, by Implant Type USD Million (2023-2028)
  • Table 178. Asia Pacific Artificial Tendons and Ligaments, by Material Type USD Million (2023-2028)
  • Table 179. Asia Pacific Artificial Tendons and Ligaments, by End-Use USD Million (2023-2028)
  • Table 180. China Artificial Tendons and Ligaments, by Application USD Million (2023-2028)
  • Table 181. China Artificial Tendons and Ligaments, by Implant Type USD Million (2023-2028)
  • Table 182. China Artificial Tendons and Ligaments, by Material Type USD Million (2023-2028)
  • Table 183. China Artificial Tendons and Ligaments, by End-Use USD Million (2023-2028)
  • Table 184. Japan Artificial Tendons and Ligaments, by Application USD Million (2023-2028)
  • Table 185. Japan Artificial Tendons and Ligaments, by Implant Type USD Million (2023-2028)
  • Table 186. Japan Artificial Tendons and Ligaments, by Material Type USD Million (2023-2028)
  • Table 187. Japan Artificial Tendons and Ligaments, by End-Use USD Million (2023-2028)
  • Table 188. India Artificial Tendons and Ligaments, by Application USD Million (2023-2028)
  • Table 189. India Artificial Tendons and Ligaments, by Implant Type USD Million (2023-2028)
  • Table 190. India Artificial Tendons and Ligaments, by Material Type USD Million (2023-2028)
  • Table 191. India Artificial Tendons and Ligaments, by End-Use USD Million (2023-2028)
  • Table 192. South Korea Artificial Tendons and Ligaments, by Application USD Million (2023-2028)
  • Table 193. South Korea Artificial Tendons and Ligaments, by Implant Type USD Million (2023-2028)
  • Table 194. South Korea Artificial Tendons and Ligaments, by Material Type USD Million (2023-2028)
  • Table 195. South Korea Artificial Tendons and Ligaments, by End-Use USD Million (2023-2028)
  • Table 196. Taiwan Artificial Tendons and Ligaments, by Application USD Million (2023-2028)
  • Table 197. Taiwan Artificial Tendons and Ligaments, by Implant Type USD Million (2023-2028)
  • Table 198. Taiwan Artificial Tendons and Ligaments, by Material Type USD Million (2023-2028)
  • Table 199. Taiwan Artificial Tendons and Ligaments, by End-Use USD Million (2023-2028)
  • Table 200. Australia Artificial Tendons and Ligaments, by Application USD Million (2023-2028)
  • Table 201. Australia Artificial Tendons and Ligaments, by Implant Type USD Million (2023-2028)
  • Table 202. Australia Artificial Tendons and Ligaments, by Material Type USD Million (2023-2028)
  • Table 203. Australia Artificial Tendons and Ligaments, by End-Use USD Million (2023-2028)
  • Table 204. Rest of Asia-Pacific Artificial Tendons and Ligaments, by Application USD Million (2023-2028)
  • Table 205. Rest of Asia-Pacific Artificial Tendons and Ligaments, by Implant Type USD Million (2023-2028)
  • Table 206. Rest of Asia-Pacific Artificial Tendons and Ligaments, by Material Type USD Million (2023-2028)
  • Table 207. Rest of Asia-Pacific Artificial Tendons and Ligaments, by End-Use USD Million (2023-2028)
  • Table 208. Europe Artificial Tendons and Ligaments, by Country USD Million (2023-2028)
  • Table 209. Europe Artificial Tendons and Ligaments, by Application USD Million (2023-2028)
  • Table 210. Europe Artificial Tendons and Ligaments, by Implant Type USD Million (2023-2028)
  • Table 211. Europe Artificial Tendons and Ligaments, by Material Type USD Million (2023-2028)
  • Table 212. Europe Artificial Tendons and Ligaments, by End-Use USD Million (2023-2028)
  • Table 213. Germany Artificial Tendons and Ligaments, by Application USD Million (2023-2028)
  • Table 214. Germany Artificial Tendons and Ligaments, by Implant Type USD Million (2023-2028)
  • Table 215. Germany Artificial Tendons and Ligaments, by Material Type USD Million (2023-2028)
  • Table 216. Germany Artificial Tendons and Ligaments, by End-Use USD Million (2023-2028)
  • Table 217. France Artificial Tendons and Ligaments, by Application USD Million (2023-2028)
  • Table 218. France Artificial Tendons and Ligaments, by Implant Type USD Million (2023-2028)
  • Table 219. France Artificial Tendons and Ligaments, by Material Type USD Million (2023-2028)
  • Table 220. France Artificial Tendons and Ligaments, by End-Use USD Million (2023-2028)
  • Table 221. Italy Artificial Tendons and Ligaments, by Application USD Million (2023-2028)
  • Table 222. Italy Artificial Tendons and Ligaments, by Implant Type USD Million (2023-2028)
  • Table 223. Italy Artificial Tendons and Ligaments, by Material Type USD Million (2023-2028)
  • Table 224. Italy Artificial Tendons and Ligaments, by End-Use USD Million (2023-2028)
  • Table 225. United Kingdom Artificial Tendons and Ligaments, by Application USD Million (2023-2028)
  • Table 226. United Kingdom Artificial Tendons and Ligaments, by Implant Type USD Million (2023-2028)
  • Table 227. United Kingdom Artificial Tendons and Ligaments, by Material Type USD Million (2023-2028)
  • Table 228. United Kingdom Artificial Tendons and Ligaments, by End-Use USD Million (2023-2028)
  • Table 229. Netherlands Artificial Tendons and Ligaments, by Application USD Million (2023-2028)
  • Table 230. Netherlands Artificial Tendons and Ligaments, by Implant Type USD Million (2023-2028)
  • Table 231. Netherlands Artificial Tendons and Ligaments, by Material Type USD Million (2023-2028)
  • Table 232. Netherlands Artificial Tendons and Ligaments, by End-Use USD Million (2023-2028)
  • Table 233. Rest of Europe Artificial Tendons and Ligaments, by Application USD Million (2023-2028)
  • Table 234. Rest of Europe Artificial Tendons and Ligaments, by Implant Type USD Million (2023-2028)
  • Table 235. Rest of Europe Artificial Tendons and Ligaments, by Material Type USD Million (2023-2028)
  • Table 236. Rest of Europe Artificial Tendons and Ligaments, by End-Use USD Million (2023-2028)
  • Table 237. MEA Artificial Tendons and Ligaments, by Country USD Million (2023-2028)
  • Table 238. MEA Artificial Tendons and Ligaments, by Application USD Million (2023-2028)
  • Table 239. MEA Artificial Tendons and Ligaments, by Implant Type USD Million (2023-2028)
  • Table 240. MEA Artificial Tendons and Ligaments, by Material Type USD Million (2023-2028)
  • Table 241. MEA Artificial Tendons and Ligaments, by End-Use USD Million (2023-2028)
  • Table 242. Middle East Artificial Tendons and Ligaments, by Application USD Million (2023-2028)
  • Table 243. Middle East Artificial Tendons and Ligaments, by Implant Type USD Million (2023-2028)
  • Table 244. Middle East Artificial Tendons and Ligaments, by Material Type USD Million (2023-2028)
  • Table 245. Middle East Artificial Tendons and Ligaments, by End-Use USD Million (2023-2028)
  • Table 246. Africa Artificial Tendons and Ligaments, by Application USD Million (2023-2028)
  • Table 247. Africa Artificial Tendons and Ligaments, by Implant Type USD Million (2023-2028)
  • Table 248. Africa Artificial Tendons and Ligaments, by Material Type USD Million (2023-2028)
  • Table 249. Africa Artificial Tendons and Ligaments, by End-Use USD Million (2023-2028)
  • Table 250. North America Artificial Tendons and Ligaments, by Country USD Million (2023-2028)
  • Table 251. North America Artificial Tendons and Ligaments, by Application USD Million (2023-2028)
  • Table 252. North America Artificial Tendons and Ligaments, by Implant Type USD Million (2023-2028)
  • Table 253. North America Artificial Tendons and Ligaments, by Material Type USD Million (2023-2028)
  • Table 254. North America Artificial Tendons and Ligaments, by End-Use USD Million (2023-2028)
  • Table 255. United States Artificial Tendons and Ligaments, by Application USD Million (2023-2028)
  • Table 256. United States Artificial Tendons and Ligaments, by Implant Type USD Million (2023-2028)
  • Table 257. United States Artificial Tendons and Ligaments, by Material Type USD Million (2023-2028)
  • Table 258. United States Artificial Tendons and Ligaments, by End-Use USD Million (2023-2028)
  • Table 259. Canada Artificial Tendons and Ligaments, by Application USD Million (2023-2028)
  • Table 260. Canada Artificial Tendons and Ligaments, by Implant Type USD Million (2023-2028)
  • Table 261. Canada Artificial Tendons and Ligaments, by Material Type USD Million (2023-2028)
  • Table 262. Canada Artificial Tendons and Ligaments, by End-Use USD Million (2023-2028)
  • Table 263. Mexico Artificial Tendons and Ligaments, by Application USD Million (2023-2028)
  • Table 264. Mexico Artificial Tendons and Ligaments, by Implant Type USD Million (2023-2028)
  • Table 265. Mexico Artificial Tendons and Ligaments, by Material Type USD Million (2023-2028)
  • Table 266. Mexico Artificial Tendons and Ligaments, by End-Use USD Million (2023-2028)
  • Table 267. Research Programs/Design for This Report
  • Table 268. Key Data Information from Secondary Sources
  • Table 269. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Artificial Tendons and Ligaments: by Application USD Million (2017-2022)
  • Figure 5. Global Artificial Tendons and Ligaments: by Implant Type USD Million (2017-2022)
  • Figure 6. Global Artificial Tendons and Ligaments: by Material Type USD Million (2017-2022)
  • Figure 7. Global Artificial Tendons and Ligaments: by End-Use USD Million (2017-2022)
  • Figure 8. South America Artificial Tendons and Ligaments Share (%), by Country
  • Figure 9. Asia Pacific Artificial Tendons and Ligaments Share (%), by Country
  • Figure 10. Europe Artificial Tendons and Ligaments Share (%), by Country
  • Figure 11. MEA Artificial Tendons and Ligaments Share (%), by Country
  • Figure 12. North America Artificial Tendons and Ligaments Share (%), by Country
  • Figure 13. Global Artificial Tendons and Ligaments share by Players 2022 (%)
  • Figure 14. Global Artificial Tendons and Ligaments share by Players (Top 3) 2022(%)
  • Figure 15. Global Artificial Tendons and Ligaments share by Players (Top 5) 2022(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Lars (France) Revenue, Net Income and Gross profit
  • Figure 18. Lars (France) Revenue: by Geography 2022
  • Figure 19. Corin Group (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 20. Corin Group (United Kingdom) Revenue: by Geography 2022
  • Figure 21. Neoligaments (Xiros) (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 22. Neoligaments (Xiros) (United Kingdom) Revenue: by Geography 2022
  • Figure 23. Cousin Biotech (France) Revenue, Net Income and Gross profit
  • Figure 24. Cousin Biotech (France) Revenue: by Geography 2022
  • Figure 25. FX Solutions (France) Revenue, Net Income and Gross profit
  • Figure 26. FX Solutions (France) Revenue: by Geography 2022
  • Figure 27. Orthomed S.A.S. (France) Revenue, Net Income and Gross profit
  • Figure 28. Orthomed S.A.S. (France) Revenue: by Geography 2022
  • Figure 29. Shanghai Pine&Power Biotech (China) Revenue, Net Income and Gross profit
  • Figure 30. Shanghai Pine&Power Biotech (China) Revenue: by Geography 2022
  • Figure 31. Mathys AG Bettlach (Switzerland) Revenue, Net Income and Gross profit
  • Figure 32. Mathys AG Bettlach (Switzerland) Revenue: by Geography 2022
  • Figure 33. Global Artificial Tendons and Ligaments: by Application USD Million (2023-2028)
  • Figure 34. Global Artificial Tendons and Ligaments: by Implant Type USD Million (2023-2028)
  • Figure 35. Global Artificial Tendons and Ligaments: by Material Type USD Million (2023-2028)
  • Figure 36. Global Artificial Tendons and Ligaments: by End-Use USD Million (2023-2028)
  • Figure 37. South America Artificial Tendons and Ligaments Share (%), by Country
  • Figure 38. Asia Pacific Artificial Tendons and Ligaments Share (%), by Country
  • Figure 39. Europe Artificial Tendons and Ligaments Share (%), by Country
  • Figure 40. MEA Artificial Tendons and Ligaments Share (%), by Country
  • Figure 41. North America Artificial Tendons and Ligaments Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Lars (France)
  • Corin Group (United Kingdom)
  • Neoligaments (Xiros) (United Kingdom)
  • Cousin Biotech (France)
  • FX Solutions (France)
  • Orthomed S.A.S. (France)
  • Shanghai Pine&Power Biotech (China)
  • Mathys AG Bettlach (Switzerland)
Select User Access Type

Key Highlights of Report


Apr 2023 222 Pages 72 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Artificial Tendons and Ligaments Quantitative research analysis
Global Artificial Tendons and Ligaments Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

"Increasing Sports-Related Injuries " is seen as one of major growth factors of Artificial Tendons and Ligaments Market in years to come.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
The Artificial Tendons and Ligaments market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete of companies available in our research coverage.

Know More About Global Artificial Tendons and Ligaments Report?

Have a Query? Click Here

Other Related Reports

Atherosclerosis Comprehensive Study by Treatment (Medication, Catheter-based Procedures (Balloon angioplasty, Atherectomy), Surgery (Endarterectomy, Arterioplasty, Bypass)), Distribution Channel (Hos...
$ 3450
Blood Coagulants Comprehensive Study by Type (Aprotinin, Tranexamic Acid (TXA), Epsilon-Aminocaproic acid, Aminomethylbenzoic acid, Other), Application (Hemophilia, Surgery (Post-Operative Care), Men...
$ 3750
Dural Repair Comprehensive Study by Type (Sheets, Patches, Plugs, Glues, Others), Application (Neurosurgery, Spine Surgery, Maxillofacial Surgery, Others), End Users (Hospitals, Clinics, Research Ins...
$ 3500
Dysautonomia Comprehensive Study by Type (Neurocardiogenic Syncope, Postural Orthostatic Tachycardia Syndrome, Multiple System Atrophy, Autonomic Dysreflexia, Baroreflex Failure, Others), Treatment (...
$ 3750
Coronavirus Comprehensive Study by Type (Middle East Respiratory Syndrome (MERS) {MER-CoV}, Severe Acute Respiratory Syndrome (SARS) {SAR-CoV}), Application (Hospitals, Research Laboratories, Clinics...
$ 3650
Hunter Syndrome Treatment Comprehensive Study by Type (Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT), Others), End-user (Life Science Companies, Research Institutes, Hos...
$ 3500